CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-04 | ROBINS CHAD M CEO and Chairman | Grant or award | +355,000 | 2,931,701 | ||
| 2025-03-04 | Pellini Michael J Director | Grant or award | +15,394 | 69,690 | ||
| 2025-03-04 | Pellini Michael J Director | Grant or award · Stock Option (right to buy) | +23,726 | 23,726 | ||
| 2025-03-04 | OWEN KATEY EINTERZ Director | Grant or award | +15,394 | 72,629 | ||
| 2025-03-04 | OWEN KATEY EINTERZ Director | Grant or award · Stock Option (right to buy) | +23,726 | 23,726 | ||
| 2025-03-04 | NEUPERT PETER M Director | Grant or award | +15,394 | 184,690 | ||
| 2025-03-04 | NEUPERT PETER M Director | Grant or award · Stock Option (right to buy) | +23,726 | 23,726 | ||
| 2025-03-04 | HERSHBERG ROBERT Director | Grant or award | +15,394 | 122,690 | ||
| 2025-03-04 | HERSHBERG ROBERT Director | Grant or award · Stock Option (right to buy) | +23,726 | 23,726 | ||
| 2025-03-04 | GRIFFIN MICHELLE RENEE Director | Grant or award 10b5-1 | +15,394 | 67,349 | ||
| 2025-03-04 | GRIFFIN MICHELLE RENEE Director | Grant or award · Stock Option (right to buy) 10b5-1 | +23,726 | 23,726 | ||
| 2025-02-20 | ROBINS CHAD M CEO and Chairman | Option exercise 10b5-1 | +99,107 | $6.32 | $626K | 2,675,808 |
| 2025-02-20 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −99,107 | $8.44 | $836K | 2,576,701 |
| 2025-02-20 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (right to buy) 10b5-1 | −99,107 | 0 | ||
| 2025-02-19 | ROBINS CHAD M CEO and Chairman | Option exercise 10b5-1 | +186,080 | $6.32 | $1.2M | 2,762,781 |
| 2025-02-19 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −186,080 | $8.46 | $1.6M | 2,576,701 |
| 2025-02-19 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (right to buy) 10b5-1 | −186,080 | 99,107 | ||
| 2025-02-18 | ROBINS CHAD M CEO and Chairman | Option exercise 10b5-1 | +211,160 | $6.32 | $1.3M | 2,787,861 |
| 2025-02-18 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −211,160 | $8.50 | $1.8M | 2,576,701 |
| 2025-02-18 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (right to buy) 10b5-1 | −211,160 | 285,187 |
Page 28 of 120 · 2,386 trades